HRTX Archived Articles
Heron Therapeutics (HRTX): Navigating Challenges and Charting a Path to Profitability
Published on March 07, 2025
Heron Therapeutics (NASDAQ:HRTX) Poised for Profitability as Acute Care and Oncology Portfolios Deliver Strong Growth
Published on September 24, 2024